The Banff 97 working classification of renal allograft pathology.

PubWeight™: 9.02‹?› | Rank: Top 0.1%

🔗 View Article (PMID 9987096)

Published in Kidney Int on February 01, 1999


L C Racusen1, K Solez, R B Colvin, S M Bonsib, M C Castro, T Cavallo, B P Croker, A J Demetris, C B Drachenberg, A B Fogo, P Furness, L W Gaber, I W Gibson, D Glotz, J C Goldberg, J Grande, P F Halloran, H E Hansen, B Hartley, P J Hayry, C M Hill, E O Hoffman, L G Hunsicker, A S Lindblad, Y Yamaguchi

Author Affiliations

1: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Associated clinical trials:

Molecular Biomarkers in Renal Transplantation Via TruGraf® Test | NCT04398498

Articles citing this

(truncated to the top 100)

Tolerogenic immunosuppression for organ transplantation. Lancet (2003) 4.09

Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am J Respir Crit Care Med (2013) 3.25

Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury. Kidney Int (2007) 2.86

Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci U S A (2007) 2.27

A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant (2012) 2.25

Fibrosis with inflammation at one year predicts transplant functional decline. J Am Soc Nephrol (2010) 2.09

Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. J Am Soc Nephrol (2009) 2.08

The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med (2010) 2.06

High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation (2007) 2.01

Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg (2005) 1.93

Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study. Crit Care (2011) 1.81

A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies. Kidney Int (2011) 1.77

Kidney pathological changes in metabolic syndrome: a cross-sectional study. Am J Kidney Dis (2009) 1.74

The impact of donor-specific anti-HLA antibodies on late kidney allograft failure. Nat Rev Nephrol (2012) 1.71

Acp. Best practice no 160. Renal biopsy specimens. J Clin Pathol (2000) 1.69

Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients. Kidney Int (2009) 1.68

Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant (2010) 1.65

Urine proteomics to detect biomarkers for chronic allograft dysfunction. J Am Soc Nephrol (2008) 1.62

A molecular classifier for predicting future graft loss in late kidney transplant biopsies. J Clin Invest (2010) 1.61

Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study. BMJ (2009) 1.61

Alemtuzumab induction in pediatric kidney transplantation. Pediatr Transplant (2013) 1.54

Statin use is associated with prolonged survival of renal transplant recipients. J Am Soc Nephrol (2008) 1.54

Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg (2003) 1.52

An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant (2001) 1.48

Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures. Proc Natl Acad Sci U S A (2009) 1.47

Complete steroid avoidance is effective and safe in children with renal transplants: a multicenter randomized trial with three-year follow-up. Am J Transplant (2012) 1.45

Study of the effect of donor source on graft and patient survival in pediatric renal transplant recipients. Pediatr Nephrol (2008) 1.44

Interleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejection. J Exp Med (2008) 1.41

Antithymocyte treatment of steroid-resistant acute rejection in renal transplantation. Pediatr Nephrol (2011) 1.40

Transcriptional Perturbations in Graft Rejection. Transplantation (2015) 1.40

Early epithelial phenotypic changes predict graft fibrosis. J Am Soc Nephrol (2008) 1.29

MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA. Am J Transplant (2011) 1.27

19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells. Magn Reson Med (2011) 1.27

Tubulointerstitial damage as the major pathological lesion in endemic chronic kidney disease among farmers in North Central Province of Sri Lanka. Environ Health Prev Med (2011) 1.20

Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction. Mol Cell Proteomics (2009) 1.18

Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model. Proc Natl Acad Sci U S A (2009) 1.18

13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy. Am J Pathol (2005) 1.17

Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation. J Am Soc Nephrol (2011) 1.17

Modified C-reactive protein might be a target autoantigen of TINU syndrome. Clin J Am Soc Nephrol (2010) 1.16

Association of kidney function and metabolic risk factors with density of glomeruli on renal biopsy samples from living donors. Mayo Clin Proc (2011) 1.15

Monocyte infiltration and kidney allograft dysfunction during acute rejection. Am J Transplant (2008) 1.15

OSAKA trial: a randomized, controlled trial comparing tacrolimus QD and BD in kidney transplantation. Transplantation (2013) 1.14

Pathological and clinical characterization of the 'troubled transplant': data from the DeKAF study. Am J Transplant (2010) 1.14

Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion. Am J Transplant (2013) 1.14

Proteomic signatures in plasma during early acute renal allograft rejection. Mol Cell Proteomics (2010) 1.14

Revisiting traditional risk factors for rejection and graft loss after kidney transplantation. Am J Transplant (2011) 1.14

Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies. J Am Soc Nephrol (2010) 1.13

Urine high and low molecular weight proteins one-year post-kidney transplant: relationship to histology and graft survival. Am J Transplant (2013) 1.12

Nox-2 is a modulator of fibrogenesis in kidney allografts. Am J Transplant (2008) 1.11

Late kidney allograft loss: what we know about it, and what we can do about it. Clin J Am Soc Nephrol (2008) 1.11

Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys. Am J Transplant (2008) 1.11

Combination of peritubular c4d and transplant glomerulopathy predicts late renal allograft failure. J Am Soc Nephrol (2009) 1.11

5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol (2012) 1.10

Tissue elasticity estimated by acoustic radiation force impulse quantification depends on the applied transducer force: an experimental study in kidney transplant patients. Eur Radiol (2012) 1.09

Utility of urine eosinophils in the diagnosis of acute interstitial nephritis. Clin J Am Soc Nephrol (2013) 1.08

Evaluation of renal allograft function early after transplantation with diffusion-weighted MR imaging. Eur Radiol (2009) 1.07

Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation. J Am Soc Nephrol (2011) 1.07

IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury. J Am Soc Nephrol (2015) 1.07

Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation. J Am Soc Nephrol (2011) 1.06

Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies. Clin J Am Soc Nephrol (2008) 1.06

The evolution of the Banff classification schema for diagnosing renal allograft rejection and its implications for clinicians. Indian J Nephrol (2010) 1.05

Tubulointerstitial nephritis with uveitis in Chinese adults. Clin J Am Soc Nephrol (2013) 1.05

Renal pathology of ANCA-related vasculitis: proposal for standardization of pathological diagnosis in Japan. Clin Exp Nephrol (2008) 1.05

C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts. J Am Soc Nephrol (2008) 1.04

TGF expression and macrophage accumulation in atherosclerotic renal artery stenosis. Clin J Am Soc Nephrol (2012) 1.04

Molecular correlates of renal function in kidney transplant biopsies. J Am Soc Nephrol (2009) 1.03

USPIO-enhanced MR imaging of macrophage infiltration in native and transplanted kidneys: initial results in humans. Eur Radiol (2007) 1.03

Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood. PLoS One (2009) 1.03

Presence of urinary Haufen accurately predicts polyomavirus nephropathy. J Am Soc Nephrol (2009) 1.03

Mitogenic modulation of Ca2+ -activated K+ channels in proliferating A7r5 vascular smooth muscle cells. Br J Pharmacol (2006) 1.02

Renal allograft pathology with C4d immunostaining in patients with graft dysfunction. Indian J Nephrol (2011) 1.02

Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy? Am J Pathol (2003) 1.02

2202 kidney transplant recipients with 10 years of graft function: what happens next? Am J Transplant (2008) 1.02

The two kidney to one kidney transition and transplant glomerulopathy: a podocyte perspective. J Am Soc Nephrol (2014) 1.01

Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study. Clin J Am Soc Nephrol (2010) 1.01

Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts. J Am Soc Nephrol (2015) 1.00

Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers. Transplantation (2010) 0.99

Early loss of peritubular capillaries after kidney transplantation. J Am Soc Nephrol (2011) 0.99

MR elastography in renal transplant patients and correlation with renal allograft biopsy: a feasibility study. Acad Radiol (2012) 0.99

Telomere shortening and cellular senescence in a model of chronic renal allograft rejection. Am J Pathol (2003) 0.98

Quantitative patterns of azathioprine adherence after renal transplantation. Transplantation (2009) 0.97

ABO incompatible renal transplants: Good or bad? World J Transplant (2014) 0.97

Non-invasive imaging of acute renal allograft rejection in rats using small animal F-FDG-PET. PLoS One (2009) 0.97

Quantitative elastography of renal transplants using supersonic shear imaging: a pilot study. Eur Radiol (2012) 0.97

Multiparametric and semiquantitative scoring systems for the evaluation of mouse model histopathology--a systematic review. BMC Vet Res (2013) 0.97

Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits. Am J Transplant (2009) 0.96

Focal C4d+ in renal allografts is associated with the presence of donor-specific antibodies and decreased allograft survival. Am J Transplant (2009) 0.96

Choice of induction regimens on the risk of cytomegalovirus infection in donor-positive and recipient-negative kidney transplant recipients. Transpl Infect Dis (2010) 0.94

Sensitized renal transplant recipients: current protocols and future directions. Nat Rev Nephrol (2010) 0.94

Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis. Mol Med (2008) 0.94

Isolated endarteritis and kidney transplant survival: a multicenter collaborative study. J Am Soc Nephrol (2014) 0.94

A rapid noninvasive assay for the detection of renal transplant injury. Transplantation (2013) 0.93

Epithelial-to-mesenchymal transition in early transplant tubulointerstitial damage. J Am Soc Nephrol (2008) 0.93

Pathological significance of a panel of urinary biomarkers in patients with drug-induced tubulointerstitial nephritis. Clin J Am Soc Nephrol (2010) 0.93

Mycophenolic acid may delay allograft fibrosis by inhibiting transforming growth factor-beta1-induced activation of Nox-2 through the nuclear factor-kappaB pathway. Transplantation (2010) 0.93

Subendothelial heparan sulfate proteoglycans become major L-selectin and monocyte chemoattractant protein-1 ligands upon renal ischemia/reperfusion. Am J Pathol (2007) 0.92

Endothelial cells present antigens in vivo. BMC Immunol (2004) 0.92

Ultra-localization of Foxp3+ T cells within renal allografts shows infiltration of tubules mimicking rejection. Am J Pathol (2007) 0.92

Integrative analysis of -omics data and histologic scoring in renal disease and transplantation: renal histogenomics. Semin Nephrol (2010) 0.91

Central Role of CD45RA- Foxp3hi Memory Regulatory T Cells in Clinical Kidney Transplantation Tolerance. J Am Soc Nephrol (2015) 0.91

Articles by these authors

Identification of a major co-receptor for primary isolates of HIV-1. Nature (1996) 23.81

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med (1993) 18.15

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer (1980) 10.11

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care (1997) 8.52

Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09

DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev (1998) 6.96

Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest (1981) 6.89

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med (1995) 5.50

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3). J Immunol (1973) 4.78

Liver transplantation (1). N Engl J Med (1989) 4.53

Proteoglycans as modulators of growth factor activities. Cell (1991) 4.45

Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science (1999) 4.43

A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. N Engl J Med (1992) 4.33

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. EMBO J (1998) 4.08

Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant (2011) 4.06

The effect of the volume of procedures at transplantation centers on mortality after liver transplantation. N Engl J Med (1999) 4.03

Baboon-to-human liver transplantation. Lancet (1993) 4.01

Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest (1996) 3.73

Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med (1981) 3.63

Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc (1987) 3.55

Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant (2009) 3.43

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43

BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med (2001) 3.40

Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36

Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant (2006) 3.34

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J (1999) 3.19

Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation (1995) 3.18

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16

Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation (1993) 3.13

Orthotopic liver transplantation in dogs receiving FK-506. Transplant Proc (1987) 3.11

International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int (1993) 3.11

Evolutionary motif and its biological and structural significance. J Mol Evol (1997) 3.03

Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J Exp Med (1997) 2.99

Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98

Chronic renal lesions following long-term treatment with lithium. Kidney Int (1977) 2.95

Liver transplantation (2). N Engl J Med (1989) 2.93

Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. Am J Kidney Dis (1990) 2.91

Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res (1997) 2.91

Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91

Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol (1983) 2.90

A highly purified RNA polymerase II elongation control system. J Biol Chem (2001) 2.84

Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci U S A (2000) 2.82

The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81

Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest (2001) 2.79

An epidemiological study of the magnitude and consequences of work related violence: the Minnesota Nurses' Study. Occup Environ Med (2004) 2.78

Role of the clotting system in cell-mediated hypersensitivity. I. Fibrin deposition in delayed skin reactions in man. J Exp Med (1973) 2.75

Tolerance versus immunosuppression: a perspective. Am J Transplant (2008) 2.71

A review of adult and pediatric post-transplant liver pathology. Pathol Annu (1987) 2.62

Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med (2000) 2.61

The morphology of "acute tubular necrosis" in man: analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine (Baltimore) (1979) 2.58

Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer (1971) 2.56

The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA (1993) 2.54

Molecular cloning and expression of a member of the aquaporin family with permeability to glycerol and urea in addition to water expressed at the basolateral membrane of kidney collecting duct cells. Proc Natl Acad Sci U S A (1994) 2.54

EphB/syndecan-2 signaling in dendritic spine morphogenesis. Neuron (2001) 2.53

FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50

Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med (1994) 2.48

Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant (2012) 2.46

Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med (1998) 2.40

The oncornavirus glycoprotein gp69/71: a constituent of the surface of normal and malignant thymocytes. J Exp Med (1975) 2.37

Clonal dominance among T-lymphocyte infiltrates in arthritis. Proc Natl Acad Sci U S A (1988) 2.36

Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon. J Exp Med (1985) 2.34